You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer

 

Online download statistics by month:

Online download statistics by month: July 2021 to August 2025

AbstractFullPdf
Jul 202120920979
Aug 2021732733270
Sep 2021268268125
Oct 2021311311109
Nov 202121121285
Dec 2021222229101
Jan 2022176195111
Feb 2022213221122
Mar 2022257273163
Apr 202217519495
May 2022230247137
Jun 202217518676
Jul 202212212980
Aug 2022141155111
Sep 202216017789
Oct 2022234252112
Nov 202216616783
Dec 202213513667
Jan 202315215380
Feb 202320420683
Mar 202319519890
Apr 202313513779
May 202313213484
Jun 202310610861
Jul 202310710867
Aug 202312712773
Sep 202311611659
Oct 202316516773
Nov 202320320342
Dec 202322222286
Jan 2024161163146
Feb 202413513774
Mar 2024140140108
Apr 202412312585
May 2024939462
Jun 202411211199
Jul 202412412977
Aug 2024747661
Sep 202487881040
Oct 202411411459
Nov 202411912073
Dec 2024190191111
Jan 202517217490
Feb 2025919249
Mar 2025939376
Apr 202514915091
May 202510510660
Jun 2025858547
Jul 2025110
Aug 2025110
Total817083635300